{
    "type": "ETF",
    "ucits": true,
    "fund_name": "UBS (Lux) Fund Solutions - MSCI Emerging Markets UCITS ETF",
    "investment_objective": "Passive management aiming to replicate the MSCI Emerging Markets Index (Net Return) using a representative sampling strategy and portfolio optimization; may use derivatives where direct replication is not possible or practical to gain exposure or efficiencies.",
    "primary_asset_class": "Equity",
    "geographic_focus": "Emerging Markets (21 countries including China, Taiwan, India, South Korea, Brazil, etc.)",
    "replication_method": "physical",
    "swaps": true,
    "derivatives": false,
    "leverage": false,
    "inverse": false,
    "complex_factors": "Swaps, Counterparty Risk",
    "classification": "complex",
    "supporting_data": "The ETF primarily uses physical replication via stratified sampling of the MSCI Emerging Markets Index, investing directly in equities. However, the KIID and PRIIPs KID explicitly state that the fund may use derivatives, including OTC derivatives and swap agreements, to gain exposure where direct replication is not possible or practical, or to generate efficiencies. This use of OTC derivatives introduces counterparty risk, which is mitigated by a collateral policy but remains a complexity factor. The fund does not employ leverage or inverse strategies, and the derivatives are used as an inherent part of the investment strategy rather than solely for risk management, so 'derivatives' is marked false per instructions. The PRIIPs KID risk indicator is medium (4/7), but the KIID risk rating is higher (6/7) due to emerging market volatility. The fund is UCITS compliant. No capital protection or structured features are present. Costs are straightforward with a TER of 0.18%, no performance fees, and no complex fee structures. The fund invests in liquid, transparent equity securities but the partial use of swaps and OTC derivatives, and the associated counterparty risk, trigger MiFID II complexity classification. There is no leverage or inverse exposure. The fund tracks a broad, well-known index without complex structured products or contingent bonds. The monthly factsheet confirms physical replication with a small portion of derivatives used for hard-to-access markets, consistent with the documents. No mention of funded or unfunded swaps, or synthetic replication as the primary method. The presence of OTC derivatives and swap usage, even if limited, mandates classification as complex under MiFID II rules. No PRIIPs comprehension warnings or capital protection features were found.",
    "risk_level_assessment": "The KIID assigns a risk category of 6 out of 7 due to the volatility of emerging market equities, indicating high market risk but not complexity per se. The PRIIPs KID shows a medium risk level (4/7), reflecting a more moderate risk view. The elevated risk rating aligns with the underlying asset class and market exposure rather than structural complexity. The complexity classification is driven primarily by the use of OTC derivatives and swap agreements, which introduce counterparty risk and complexity beyond simple physical replication."
}